KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Treasury Shares (2019 - 2025)

Historic Treasury Shares for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to $11.5 million.

  • Adaptive Biotechnologies' Treasury Shares rose 943.44% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 943.44%. This contributed to the annual value of $10.2 million for FY2024, which is 522.67% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Treasury Shares is $11.5 million, which was up 943.44% from $11.6 million recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Treasury Shares peaked at $12.0 million during Q1 2024, and registered a low of $651649.0 during Q1 2021.
  • Moreover, its 5-year median value for Treasury Shares was $9.9 million (2023), whereas its average is $7.7 million.
  • In the last 5 years, Adaptive Biotechnologies' Treasury Shares skyrocketed by 2886217.78% in 2021 and then crashed by 173.77% in 2025.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Treasury Shares stood at $1.2 million in 2021, then surged by 393.87% to $6.0 million in 2022, then skyrocketed by 61.65% to $9.7 million in 2023, then rose by 5.23% to $10.2 million in 2024, then increased by 12.64% to $11.5 million in 2025.
  • Its Treasury Shares stands at $11.5 million for Q3 2025, versus $11.6 million for Q2 2025 and $11.8 million for Q1 2025.